Only real resistance now is at .0917 Then Massive Breakout Potential.
AI Machine Learning for the Health care sector Pharmaceutical industry and Big Pharma is where the focus is for ITOX
What Markets We Serve
SMART MANUFACTURING
We help our customers maintain machine uptime and maximize operational efficiency. We also enable then to do energy monitoring, predictive maintenance that anticipates problems before they happen, and improve part and process quality.
BIOTECH, PHARMACEUTICAL, AND MEDICAL DEVICES
We are on the operations side, not the patient-facing side. In this market vertical, our customers must provide very high quality products that must also pass rigorous review by governing bodies like the FDA. Here again, we focus on machine uptime, operational efficiency, and predictive maintenance to avoid unplanned downtime. SMART INFRASTRUCTURE
For bridges and other civil infrastructure, local, state and federal agencies have limited resources. We help our clients prioritize how to spend limited funds by addressing those fixes which need to be made first.
CAMBRIDGE, MA / ACCESSWIRE / May 1, 2020 / IIOT-OXYS, Inc. (OTC PINK:ITOX) announced a business update on COVID-19. Cliff Emmons, CEO of IIOT-OXYS, Inc. stated, "IIOT-OXYS, Inc. has taken decisive steps in response to the COVID-19 pandemic, and is positioned for growth due to these actions." To ensure the health and safety of its employees, all employees and contractors are working remotely. As shelter in place orders are relaxed, employees will adhere to governmental guidelines for social distancing, facial masking, and other governmental recommendations.
IIOT-OXYS, Inc. has applied for and received funding from the Payroll Protection Program (PPP). This funding will enable employees to continue supporting current and future customers remotely. "IIOT-OXYS, Inc. is primarily a Software as a Service (SaaS) company, which allows us to conduct the majority of our business remotely", commented Mr. Emmons, "Our products and services support medical device, pharmaceutical and biotech manufacturing operations, industries that are receiving significant public and private financing due to these industries' efforts to ramp up current and new diagnostics, vaccines, and therapies to fight this pandemic. Furthermore, we're pleased with the positive impact of entering a collaboration agreement with Aingura IIoT, S.L., announced in March, both in terms of customer support and potential future growth in all our target industries."
Mind Numbing Returns are coming 10-20x ROI from these levels. This is the bleeding cutting edge technology AI Machine Learning With A Top flight CEO 20 years as VP at Medtronics and a seasoned team around him.
News 
Market Data 
Discover 
